A prospective non-comparative study to assess the effectiveness and safety of combination laxative therapy containing milk of magnesia, liquid paraffin and sodium picosulphate (Cremaffin-Plus®) in the management of constipation in patients with anal fissure/hemorrhoids/obstructive defecation syndrome

Roy Patankar; Ajeet Mishra

doi:10.18203/2349-2902.isj20175160

Authors

Roy Patankar Department of Digestive Disease, Zen Hospital, Chembur East, Mumbai-400071, Maharashtra, India
Ajeet Mishra Department of Digestive Disease, Zen Hospital, Chembur East, Mumbai-400071, Maharashtra, India

DOI:

https://doi.org/10.18203/2349-2902.isj20175160

Keywords:

Anal fissure, Constipation, Hemorrhoids, Milk of magnesia, Obstructive defecation syndrome, PAC-QoL, Sodium picosulphate

Abstract

Background: Assess the effectiveness and safety of combination laxative therapy containing milk of magnesia, liquid paraffin and sodium picosulphate (Cremaffin-Plus®) in management of constipation, in patients with anal fissure/haemorrhoids/obstructive defecation syndrome (ODS).

Methods: Patients visiting study site with complaints of constipation secondary to anal fissures/haemorrhoids/ODS, intended to receive combination laxative therapy (as per physicians’ discretion), were enrolled. Primary objectives were to assess the change in number of bowel movements per day and stool consistency; secondary objectives were to assess change in straining, physician global efficacy assessment, quality of life (PAC-QOL score), Constipation Symptoms (CSS), Fecal Incontinence Score (FIS), Patient Assessment of Constipation Symptoms (PAC-SYM) score, along with the Modified Longo Score (MODS) for ODS from baseline to end of 4 weeks. Safety, tolerability and treatment adherence were also assessed.

Results: About 32 patients (anal fissure:19, haemorrhoids:5, ODS:8) met inclusion criteria. Significant improvement in stool frequency was observed in all patients pooled together (p=0.016); group wise, statistical significance was noted in patients of anal fissures. Stool consistency was improved in all patients pooled together (p<0.001); group wise, significant improvement was seen in patients of anal fissure and ODS. There was a significant improvement in straining noted in all patients pooled together (p=0.002). Significant reduction (p<0.001) was noted in all the symptom scores (CSS, FIS, PAC-SYM and PAC-QOL) from baseline to 4 weeks in all patients. About 51.44% reduction in MODS score was noted in patients with ODS.

Conclusions: Improvement in stool frequency, consistency and straining was noted in all patients with constipation (with fissure/haemorrhoids/ODS) treated with Cremaffin-plus for 4-weeks, improving the quality of life. All patients showed good therapy adherence with better safety and tolerability profile.

Metrics

Metrics Loading ...

References

Surrenti E, Rath DM, Pemberton JH, Camilleri M. Audit of constipation in a tertiary referral gastroenterology practice. Am J Gastroenterol. 1995;90(9):1471-5.

Lembo A, Camilleri M. Chronic constipation. N Engl J Med. 2003;349(14):1360-8.

Bharucha AE. American Gastroenterological Association Medical Position Statement on Constipation. Gastroenterol. 2013;144:211-7.

Ellis CN, Essani R. Treatment of obstructed defecation. Clin Colon Rectal Surg. 2012;25(1):24-33.

Kinnunen O, Salokannel J. Constipation in elderly long-stay patients: its treatment by magnesium hydroxide and bulk-laxative. Ann Clin Res. 1987;19(5):321-3.

Sharif F, Crushell E, O’Driscoll K, Bourke B. Liquid paraffin: a reappraisal of its role in the treatment of constipation. Arch Dis Child. 2001;85(2):121-4.

Hoy S, Scott L, Wagstaff A. Sodium picosulfate/magnesium citrate: a review of its use as a colorectal cleanser. Drugs. 2009;69(1):123-36.

Kienzle-Horn S, Vix J-M, Schuijt C, Peil H, Jordan CC, Kamm MA. Comparison of bisacodyl and sodium picosulphate in the treatment of chronic constipation. Curr Med Res Opin. 2007;23(4):691-9.

MOHFW (Govt. of India). Drugs and Cosmetics (Third Amendment) Rules. New Delhi: Govt. of India; 2014 p. G.S.R. 292 (E). Available at http://www.cdsco.nic.in/forms/list.aspx?lid=1833&Id=31.

ICMR (Govt. of India). Ethical Guidelines for Biomedical Research on Human Participants. India; 2006. Available at http://icmr.nic.in/ethical_guidelines.pdf.

Constipation Treatment [Internet]. World Gastroenterology Institute - Hospital for Digestive Diseases. [cited 2017 Oct 10]. Available at http://www.wgi.ooo/Constipation.aspx

CADTH. Treatments for Constipation: A Review of Systematic Reviews. Canadian Agency for Drugs and Technologies in Health [CADTH] Rapid Response Reports. 2014. Available at https://www.cadth.ca/treatments-constipation-review-systematic-reviews.

Gallagher PF, O’Mahony D, Quigley EMM. Management of chronic constipation in the elderly. Drugs Aging. 2008;25(10):807-21.

Tack J, Müller-Lissner S, Stanghellini V, Boeckxstaens G, Kamm MA, Simren M, et al. Diagnosis and treatment of chronic constipation--a European perspective. Neurogastroenterol Motil. 2011;23(8):697-710.

Jamshed N. Diagnostic Approach to Chronic Constipation in Adults. Am Fam Physician. 2011;84(3):299-306.

Schlichtemeier S. Anal fissure. Aust Prescr. 2016;39(1):14-7.

Rooprai R, Bhat N, Sainani R, Mayabhate MM. Prevalence of functional constipation and constipation-predominant irritable bowel syndrome in Indian patients with constipation. Int J Basic Clin Pharmacol. 2017;6:275-85.

Wulkow R, Vix J-M, Schuijt C, Peil H, Kamm MA, Jordan C. Randomised, placebo-controlled, double-blind study to investigate the efficacy and safety of the acute use of sodium picosulphate in patients with chronic constipation. Int J Clin Pract. 2007;61(6):944-50.

Thapar RB, Patankar R V, Kamat RD, Thapar RR, Chemburkar V. MR defecography for obstructed defecation syndrome. Indian J Radiol Imaging. 2015;25(1):25-30.

Rashid A, Khuroo S. Obstructed Defecation Syndrome: A Treatise on Its Functional Variant. Intern Med. 2014;(S1):1-4.

Pucciani F. A theory of progression from obstructed defecation to fecal incontinence. Tech Coloproctol. 2015;19(12):713-5.